CASI Pharmaceuticals, Inc. (36) | Uncategorized (6)

Recent Contracts

Exhibit 1.1Underwriting Agreement, dated March 24, 2021, between CASI and Oppenheimer & Co. Inc (Filed With SEC on March 26, 2021)
Exhibit 1.1Underwriting Agreement dated July 22, 2020, between the Company and Oppenheimer & Co. Inc (Filed With SEC on July 24, 2020)
Open Market Sale AgreementSM by and between CASI Pharmaceuticals, Inc. and Jefferies LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)
Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019 (Filed With SEC on May 15, 2019)
Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019 (Filed With SEC on May 15, 2019)
Labor Contract, effective as of September 1, 2018, between CASI (Beijing) Pharmaceuticals, Inc. and Wei (Larry) Zhang (Filed With SEC on March 29, 2019)